1.
Lupus
; 18(3): 270-2, 2009 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19213868
RESUMEN
Systemic lupus erythematosus (SLE) is a multiorganic autoimmune disease that affects skin, osteoarticular and kidney frequently. Rituximab showed efficacy in treatment of osteoarticular and haematological SLE, but its use has been generalised for renal disease. In our case, we showed efficacy of rituximab in SLE articular disease, showing an ultrasonographic improvement.